Intervention by a clinical pharmacist carried out at discharge of elderly patients admitted to the internal medicine department: influence on readmissions and costs

Abstract Background Patient education on pharmacological treatment could reduce readmissions. Our objective was to carry out a pharmacist intervention focused on providing information about high-risk medications to chronic patients and to analyse its influence on readmissions and costs. Methods A si...

Full description

Saved in:
Bibliographic Details
Main Authors: Andrea Lázaro Cebas (Author), José Manuel Caro Teller (Author), Carmen García Muñoz (Author), Carlos González Gómez (Author), José Miguel Ferrari Piquero (Author), Carlos Lumbreras Bermejo (Author), José Antonio Romero Garrido (Author), Juana Benedí González (Author)
Format: Book
Published: BMC, 2022-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_f49b14ba5bae4a6899bced58d2d6280b
042 |a dc 
100 1 0 |a Andrea Lázaro Cebas  |e author 
700 1 0 |a José Manuel Caro Teller  |e author 
700 1 0 |a Carmen García Muñoz  |e author 
700 1 0 |a Carlos González Gómez  |e author 
700 1 0 |a José Miguel Ferrari Piquero  |e author 
700 1 0 |a Carlos Lumbreras Bermejo  |e author 
700 1 0 |a José Antonio Romero Garrido  |e author 
700 1 0 |a Juana Benedí González  |e author 
245 0 0 |a Intervention by a clinical pharmacist carried out at discharge of elderly patients admitted to the internal medicine department: influence on readmissions and costs 
260 |b BMC,   |c 2022-02-01T00:00:00Z. 
500 |a 10.1186/s12913-022-07582-6 
500 |a 1472-6963 
520 |a Abstract Background Patient education on pharmacological treatment could reduce readmissions. Our objective was to carry out a pharmacist intervention focused on providing information about high-risk medications to chronic patients and to analyse its influence on readmissions and costs. Methods A single-centre study with an intervention group and a retrospective control group was conducted. The intervention was carried out in all polymedicated patients ≥ 65 years who were admitted to internal medicine and signed the informed consent between June 2017 and February 2018. Patients discharged to nursing homes or long-term hospitals were excluded. The control group were all the patients who were admitted during the same months of 2014 who met the same inclusion criteria. The patients were classified according to the HOSPITAL score as having a low, intermediate, or high risk of potentially avoidable readmission. Outcome measures were 30-day readmission and cost data. To analyse the effect of the intervention on readmission, a logistic regression was performed. Results The study included 589 patients (286 intervention group; 303 control group). The readmission rate decreased from 20.13% to 16.43% in the intervention group [OR = 0.760 95% CI (0.495-1.166); p = 0.209)]. The incremental cost for the intervention to prevent one readmission was €3,091.19, and the net cost saving was €1,301.26. In the intermediate- and high-risk groups, readmissions were reduced 10.91% and 10.00%, and the net cost savings were €3,3143.15 and €3,248.71, respectively. Conclusions The pharmacist intervention achieved savings in the number of readmissions, and the net cost savings were greater in patients with intermediate and high risks of potentially avoidable readmission according to the HOSPITAL score. 
546 |a EN 
690 |a Pharmacists 
690 |a Patient readmission 
690 |a Aged 
690 |a Polypharmacy 
690 |a Cost analysis 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n BMC Health Services Research, Vol 22, Iss 1, Pp 1-9 (2022) 
787 0 |n https://doi.org/10.1186/s12913-022-07582-6 
787 0 |n https://doaj.org/toc/1472-6963 
856 4 1 |u https://doaj.org/article/f49b14ba5bae4a6899bced58d2d6280b  |z Connect to this object online.